US Stock MarketDetailed Quotes

GDRX GoodRx

Watchlist
  • 4.840
  • -0.020-0.41%
Close Nov 29 13:00 ET
  • 4.910
  • +0.070+1.45%
Post 17:01 ET
1.84BMarket Cap-121000P/E (TTM)

GoodRx Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GoodRx Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
195.65M
195.25M
-403.81K
Miss Est.
+8.72%
+8.50%
-0.21%
EPS
0.02
0.01
-0.01
Miss Est.
+126.92%
+111.11%
-58.68%
Analyst Rating
Buy

Nov 30, 2024

GoodRx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 202.982M--
--2024/Q4-- / 199.733M--
Nov 7, 20242024/Q3195.251M / 195.655M--
Aug 8, 20242024/Q2200.610M / 200.428M--
May 9, 20242024/Q1197.880M / 196.098M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 202.982M--
--2024/Q4-- / 199.733M--
Nov 7, 20242024/Q3195.251M / 195.655M--
Aug 8, 20242024/Q2200.610M / 200.428M--
May 9, 20242024/Q1197.880M / 196.098M--

Unlock Free Earnings Estimates

GoodRx Earnings Reports

  • GoodRx | 10-Q: Q3 2024 Earnings Report

    Nov 7 14:03 ET

  • GoodRx | 10-Q: Q2 2024 Earnings Report

    Aug 8 13:19 ET

  • GoodRx | 10-Q: Q1 2024 Earnings Report

    May 9 15:58 ET

  • GoodRx | 8-K: GOODRX REPORTS FIRST QUARTER 2024 RESULTS

    May 9 06:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      50.00%

    • Hold

      42.86%

    • Sell

      7.14%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data